A new feature would run in the background
Google submitted data for a new Fitbit feature that would passively monitor users’ heart rhythms to the Food and Drug Administration, the company announced today.can only check for irregular heart rhythm periodically; users have to actively decide to take a reading. The new feature would run in the background and alert people if they’re showing signs of a condition called atrial fibrillation.
“These results are extremely promising and we think will have a real impact on early detection and treatment of this important condition,” Tony Faranesh, a research scientist at Fitbit, said in a press briefing. Atrial fibrillation is associated with a higher risk of stroke, and the hope is that this type of early detection will help prevent stroke. But it’s still unclear if monitoring for atrial fibrillation via smartwatch will actually keep strokes from happening — most research focuses on whether devices are accurate, not whether using them keeps peopleFaranesh said there isn’t a clear timeline for when the new feature might be available on Fitbit devices.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA probe of Abbott facility finds quality control issuesAn inspection at the Abbott Laboratories facility in Sturgis, Michigan found a harmful bacteria on surfaces in some areas of its powdered baby formula production, the U.S. health regulator said on Tuesday.
Baca lebih lajut »
Moderna wants the FDA to authorize its COVID-19 vaccine for kids under 6Moderna wants the FDA to authorize its COVID-19 vaccine for kids under six. Here's what's next in the process. | via NPR
Baca lebih lajut »
Moderna will seek FDA emergency use authorization for its vaccine in kids under 6
Baca lebih lajut »
FDA details problems at plant behind recalled baby formulaAmong other problems, FDA inspectors found a history of contamination with the bacteria, known as cronobacter, in various parts of the plant.
Baca lebih lajut »
FDA details problems at plant behind recalled baby formulaFederal safety inspectors say baby formula maker Abbott failed to maintain sanitary conditions at the Michigan manufacturing plant recently linked to a cluster of infant illnesses.
Baca lebih lajut »
Eli Lilly's BLA for sintilimab can't be approved by FDA in present formEli Lilly & Co. undefined said Thursday it received a complete response letter (CRL) from the U.S. Food and Drug Administration regarding its Biologics...
Baca lebih lajut »